Catalyst Pharmaceuticals (CPRX) Share-based Compensation (2010 - 2026)
Catalyst Pharmaceuticals' Share-based Compensation came in at $6.26 million for Q1 2026, up 7.0% from $5.85 million a year earlier and up 10.6% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Catalyst Pharmaceuticals reported Share-based Compensation of $25.19 million, up 26.9% year-over-year; for FY2025, it was $24.78 million, up 11.4% from FY2024.
- Share-based Compensation has increased in each of the last four years, with a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $22.25 million in FY2024 (+56.1%), $14.25 million in FY2023 (+80.2%), $7.91 million in FY2022 (+30.2%) and $6.07 million in FY2021 (-3.0%).
- The five-year range for quarterly Share-based Compensation is $1.47 million (Q4 2021) to $8.25 million (Q1 2024).
- Year-over-year, Share-based Compensation has increased for four consecutive quarters, with growth averaging 19.9% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2024 (growth of 185.2%), and the weakest in Q1 2025 (a decline of 29.1%).
- Business Quant data shows CPRX's Share-based Compensation at $5.66 million (Q4 2025), $5.67 million (Q3 2025) and $7.6 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 6.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.26 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 5.67 Mn |
| Jun 30, 2025 | 7.60 Mn |
| Mar 31, 2025 | 5.85 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 4.42 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 8.25 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Sep 30, 2023 | 3.81 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 2.06 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 1.52 Mn |
API Access
Catalyst Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();